三诺生物 (300298)

Sinocare Inc.

ASZ

Tags

AI HealthcareDeepSeekSpecial Purpose LoansMedical DevicesPharmaceuticals and HealthcareContains Convertible BondsBuyback PlansGuozheng Growth IndexSmall Cap GrowthSmart HealthcarePrivate HospitalsChiNext 200 IndexChiNext InnovationChiNext Blue ChipChiNext HealthcarePharma & BiotechSZSE Medicine Equal Weight IndexShenzhen A-Share Pharmaceutical IndexCSI All-share Pharmaceutical Sector IndexSZSE 700 IndexSSE 700 Growth IndexZhongchuang Growth IndexSZSE 1000 IndexCSI 1000 Growth IndexSZSE Component Index ReturnCNI 1000 IndexCSI Medical IndexChiNext Value IndexNew Virus PreventionJuly 2022 Lock-up ExpiryConvertible Bond IssuersSmart HealthcareCOVID-19 TestingMobile HealthcareTelemedicineFTSE Russell ConceptCS High-end Manufacturing IndexSME Board Innovation IndexSZSE Pharmaceutical IndexCS Pharmaceutical TI IndexCSI 1000 Pharmaceutical IndexJuchao Small-cap IndexChiNext Basic IndexSZSE Component Pharmaceutical IndexCSI All-share Pharmaceutical IndexSZSE Pharmaceutical 50 IndexChiNext Low Volatility IndexPrivate Enterprise Development IndexSZSE Component Index Equal WeightPharmaceutical & Health 100 IndexMid-small Cap IndexZhongchuang Low Volatility IndexZhongchuang 400 IndexChiNext Emerging IndexHunan 50 IndexHunan

K-Line Chart

No K-line data available

Company NameSinocare Inc.
Listing Date2012-03-19
Issue Price29RMB
Registered Capital56026.608810k RMB
Legal RepresentativeLi Shaobo
Registered AddressNo. 265, Guyuan Road, Changsha High-tech Industrial Development Zone, Hunan Province
IndustryMedical Devices
Main BusinessResearch, development, production, and sales of point-of-care testing products utilizing biosensing technology.
Company ProfileSinocare Inc. is a high-tech enterprise dedicated to the research, development, production, and sales of rapid testing products for chronic diseases using biosensing technology. Since its establishment in 2002, the company has adhered to the corporate mission of 'Keeping Promises, Dedicated to Health.' As a National High-tech Industrialization Demonstration Project in Biomedical Engineering, Sinocare has received support from the National Innovation Fund and was among the first to obtain Quality Management System certification and the European Union CE certification. The 'Sinocare' series of blood glucose meters and matching test strips produced by the company have gained wide recognition from consumers, and the 'Sinocare' brand has been recognized as a 'China Well-known Trademark' by the State Administration for Industry and Commerce.

Stock Details

1. Key Indicators

  • Total Shares(W): 56026.73
  • Circulating A-Shares(W): 45130.07
  • Earnings Per Share(RMB): 0.3827
  • Net Assets Per Share(RMB): 5.7034
  • Operating Revenue(W RMB): 345327.15
  • Total Profit(W RMB): 19076.72
  • Net Profit Attributable to Parent(W RMB): 21100.34
  • Net Profit Growth Rate(%): -17.36
  • Weighted Return on Equity(%): 6.2800
  • Operating Cash Flow Per Share(RMB): 0.9590
  • Undistributed Profit Per Share(RMB): 2.2065
  • Capital Reserve Per Share(RMB): 1.8145

2. Main Business

The main business covers:

  • Multi-indicator detection products focusing on blood glucose and chronic disease-related indicator detection.

3. Company Basic Information

  • Company Name: Sinocare Inc.
  • Listing Date: 2012-03-19
  • Industry: Special Purpose Equipment Manufacturing (Tongdaxin Research Industry: Medical & Healthcare - Medical Devices)
  • Address: No. 265 Guyuan Road, Changsha High-tech Industrial Development Zone, Hunan Province, China.
  • Website: www.sinocare.com
  • Company Profile: On December 3, 2010, Changsha Sinocare Bio-sensing Technology Co., Ltd. held its founding meeting. Based on the audit report issued by ShineWing, the company was restructured into Changsha Sinocare Bio-sensing Technology Co., Ltd. using the net asset value of Sinocare Limited as of September 30, 2010, which was 70,012,123.27 yuan, converted into 60 million shares at a ratio of 1:0.8570, with a par value of RMB 1 per share. All assets, liabilities, business, and personnel of Sinocare Limited were succeeded by the restructured joint-stock company. On December 3, 2010, ShineWing issued a capital verification report, confirming that the company's registered capital of 60 million yuan had been fully paid. On December 8, 2010, the company obtained the "Business License" issued by the Changsha Administration for Industry and Commerce, with registration number 430193000005413 and registered capital of 60 million yuan.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hong Kong Securities Clearing Company Ltd. Northbound Funds 2566.60 5.69
2 Rayon Growth Value Hybrid Securities Investment Fund Class A Fund 1832.48 4.06
3 HuaBao CSI Medical ETF Fund 961.42 2.13
4 Rayon Balanced Value Three-Year Holding Hybrid Securities Investment Fund Class A Fund 610.00 1.35
5 Sinocare Inc. - Phase II Employee Stock Ownership Plan Asset Management Plan 552.60 1.22
6 Taiping Fengying One-Year Regular Open Bond Initiated Securities Investment Fund Fund 51.23 0.11

5. Concept Sectors

  • Convertible Bonds
  • Private Hospitals
  • Smart Healthcare
  • Artificial Intelligence
  • DeepSeek
  • AI Healthcare
  • Margin Trading & Securities Lending
  • Share Repurchase Plan
  • Special Loans
  • ChiNext 300
  • SZSE Innovation Index
  • ChiNext Innovation Index
  • ChiNext Blue Chip Index
  • ChiNext Pharmaceutical Index
  • ChiNext 200

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information